262 related articles for article (PubMed ID: 21177701)
1. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
[TBL] [Abstract][Full Text] [Related]
2. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.
Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR
Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266
[TBL] [Abstract][Full Text] [Related]
3. Serotonin Signaling Through the 5-HT
Hood KY; Mair KM; Harvey AP; Montezano AC; Touyz RM; MacLean MR
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1361-1370. PubMed ID: 28473438
[TBL] [Abstract][Full Text] [Related]
4. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.
Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR
Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646
[TBL] [Abstract][Full Text] [Related]
5. Novel interactions between the 5-HT transporter, 5-HT1B receptors and Rho kinase in vivo and in pulmonary fibroblasts.
Mair KM; MacLean MR; Morecroft I; Dempsie Y; Palmer TM
Br J Pharmacol; 2008 Oct; 155(4):606-16. PubMed ID: 18695640
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH.
White K; Loughlin L; Maqbool Z; Nilsen M; McClure J; Dempsie Y; Baker AH; MacLean MR
Physiol Genomics; 2011 Apr; 43(8):417-37. PubMed ID: 21303932
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension.
Morecroft I; Pang L; Baranowska M; Nilsen M; Loughlin L; Dempsie Y; Millet C; MacLean MR
Cardiovasc Res; 2010 Feb; 85(3):593-603. PubMed ID: 19736308
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and pulmonary hypertension--from bench to bedside?
MacLean MR; Dempsie Y
Curr Opin Pharmacol; 2009 Jun; 9(3):281-6. PubMed ID: 19286424
[TBL] [Abstract][Full Text] [Related]
9. [Serotonin hypothesis and pulmonary artery hypertension].
Kloza M; Baranowska-Kuczko M; Pędzińska-Betiuk A; Jackowski K; Kozłowska H
Postepy Hig Med Dosw (Online); 2014 Jun; 68():738-48. PubMed ID: 24934532
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen receptor alpha in pulmonary hypertension.
Wright AF; Ewart MA; Mair K; Nilsen M; Dempsie Y; Loughlin L; Maclean MR
Cardiovasc Res; 2015 May; 106(2):206-16. PubMed ID: 25765937
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-361-3p suppresses serotonin-induced proliferation in human pulmonary artery smooth muscle cells by targeting SERT.
Zhang Y; Chen Y; Chen G; Zhou Y; Yao H; Tan H
Cell Mol Biol Lett; 2020; 25():45. PubMed ID: 33061998
[TBL] [Abstract][Full Text] [Related]
12. A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension.
Wallace E; Morrell NW; Yang XD; Long L; Stevens H; Nilsen M; Loughlin L; Mair KM; Baker AH; MacLean MR
Am J Respir Crit Care Med; 2015 Jun; 191(12):1432-42. PubMed ID: 25871906
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.
Morecroft I; Murray A; Nilsen M; Gurney AM; MacLean MR
Br J Pharmacol; 2009 Aug; 157(7):1241-9. PubMed ID: 19508393
[TBL] [Abstract][Full Text] [Related]
14. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
Dempsie Y; Morecroft I; Welsh DJ; MacRitchie NA; Herold N; Loughlin L; Nilsen M; Peacock AJ; Harmar A; Bader M; MacLean MR
Circulation; 2008 Jun; 117(22):2928-37. PubMed ID: 18506000
[TBL] [Abstract][Full Text] [Related]
15. 17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension.
Liu A; Tian L; Golob M; Eickhoff JC; Boston M; Chesler NC
Hypertension; 2015 Nov; 66(5):1082-8. PubMed ID: 26418020
[TBL] [Abstract][Full Text] [Related]
16. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
Huh JW; Kim SY; Lee JH; Lee YS
Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
[TBL] [Abstract][Full Text] [Related]
17. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
18. Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries.
Morecroft I; Loughlin L; Nilsen M; Colston J; Dempsie Y; Sheward J; Harmar A; MacLean MR
J Pharmacol Exp Ther; 2005 May; 313(2):539-48. PubMed ID: 15659538
[TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model.
de Raaf MA; Kroeze Y; Middelman A; de Man FS; de Jong H; Vonk-Noordegraaf A; de Korte C; Voelkel NF; Homberg J; Bogaard HJ
Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1164-73. PubMed ID: 26386116
[TBL] [Abstract][Full Text] [Related]
20. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease.
Lawrie A; Spiekerkoetter E; Martinez EC; Ambartsumian N; Sheward WJ; MacLean MR; Harmar AJ; Schmidt AM; Lukanidin E; Rabinovitch M
Circ Res; 2005 Aug; 97(3):227-35. PubMed ID: 16002749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
